Back to List View Graph View

Mesenchymal stem cell

Mesenchymal stem cells (MSCs), also called mesenchymal stromal cells or multipotent stromal cells, are a multipotent, plastic-adherent cell type resident in the stromal compartment of many tissues — most prominently bone marrow, umbilical cord, adipose tissue, and the dental pulp of exfoliated deciduous teeth (the source of SHED).

Where the papers sit

23 papers from the last 6 months study mesenchymal stem cell directly · updated from PubMed 16 Nov 2026

Those 23 are all about one subject.

  • Regenerative Cell Therapy

    Regenerative cell therapy is being applied across inflammatory disease, tissue injury, developmental lung disease, bone repair and neurodegeneration. Work increasingly pairs cells with retinoic acid, hydrogels, nanoparticles or surface engineering to improve survival, localization and function. Mechanistic studies emphasize immunometabolic reprogramming and donor- or patient-dependent response, while imaging tracks persistence after delivery. Early clinical studies in bronchopulmonary dysplasia, graft-versus-host disease and hydrocephalus are moving translation forward, but efficacy remains indication-specific.

    23 papers

NEW DIRECTION

MSCs are modeled as a functional hematopoietic niche rather than primarily administered as therapy

The microgel bone marrow model of MSC paracrine signaling supporting hematopoietic stem cell retention uses hydrogel-encapsulated MSCs to recreate a multicellular bone-marrow environment. Whereas the other papers mainly treat MSCs as therapeutic cells, engineered graft components, or sources of regenerative factors, this study makes MSCs themselves part of an ex vivo niche that maintains long-term repopulating hematopoietic stem cells. MSC density increased hematopoietic stem-cell maintenance, and microgel encapsulation promoted niche-favorable MSC transcriptional profiles, shifting the role of MSCs from therapeutic payload to tissue-supporting infrastructure for hematopoietic stem-cell retention and culture 42248284Jun.

Papers

The 23 papers from the last 6 months that study mesenchymal stem cell directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Regenerative Cell Therapy (23)
  1. The systemic administration of multipotent mesenchymal stromal cells alters the inflammatory response in the lung during murine polymicrobial sepsis. Cell and tissue research · 31 Oct 2026 PMID 42963429
  2. Can mesenchymal stem cell and retinoic acid therapies more effectively reduce lung damage due to bronchopulmonary dysplasia? Italian journal of pediatrics · 23 Oct 2026 PMID 42920189
  3. Mesenchymal Stromal Cells Fuel Immunometabolic Reprogramming of Type 2 Conventional Dendritic Cells to Alleviate Systemic Sclerosis. Arthritis & rheumatology (Hoboken, N.J.) · 5 Oct 2026 PMID 42834011
  4. ABCB5⁺ mesenchymal stem cells enable high-ratio cellular augmentation of bone grafts without loss of osteogenic function. European journal of trauma and emergency surgery : official publication of the European Trauma Society · 3 Sept 2026 PMID 42690432
  5. Remodeling-phase wound-derived protein factors enhance mesenchymal stem cell function and improve diabetic wound healing. Molecular biology reports · 3 Sept 2026 PMID 42690285
  6. Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease. Cytotherapy · 2 Sept 2026 PMID 42685638
  7. Gelatin Methacrylate as a Mesenchymal Stem Cell Delivery Vehicle: Experimental and Semi-Quantitative Evaluation Under Metabolic Stress. Macromolecular bioscience · 2 Sept 2026 PMID 42683595
  8. High-intensity interval training versus mesenchymal stem cells in amyloid-β-induced Alzheimer's disease: comparative effects on cognitive function,hippocampal inflammation, oxidative balance, and BDNF. Biochemical and biophysical research communications · 27 Aug 2026 PMID 42659862
  9. Dual-Reporter Gene-Based Multimodal Imaging for Tracking Mesenchymal Stem Cells in Diabetic Skin Wound Repair. Stem cell reviews and reports · 12 Aug 2026 PMID 42584542
  10. Responders vs. non-responders to mesenchymal stromal cells in knee osteoarthritis: Mechanistic correlates of donor cell and patient features. Stem cell reports · 6 Aug 2026 PMID 42561945
  11. Long-Term Survival, Illness Severity, and Time-to-Treatment Analysis in Dogs with Immune-Mediated Hemolytic Anemia Following Intravenous Allogeneic Mesenchymal Stem Cell Therapy: A Multicohort Follow-Up Study. Stem cells and development · 17 Jul 2026 PMID 42466752
  12. Aptamer-functionalized stiff hydrogel for enhanced BMSC enrichment and osteogenesis. PloS one · 16 Jul 2026 PMID 42461853
  13. Helping Underdeveloped Lungs with Cells (HULC-2): mesenchymal stromal cells in extreme preterm infants at risk of developing bronchopulmonary dysplasia - a study protocol of a phase 2 multicentre double blind randomised controlled trial in Canada. BMJ open · 6 Jul 2026 PMID 42409407
  14. A one-step surface engineering strategy based on PEG-EGCG to improve systemic delivery and survival of transplanted mesenchymal stromal cells. Journal of controlled release : official journal of the Controlled Release Society · 2 Jul 2026 PMID 42392407
  15. An injectable nanoreinforced hydrogel for combined GDNF-loaded nanoparticles and mesenchymal stem cell therapy in Parkinson's disease. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 1 Jul 2026 PMID 42386013
  16. Intraventricular administration of SHED-derived mesenchymal stem cells in neonatal post- infectious hydrocephalus: a first-in-human case report. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 26 Jun 2026 PMID 42362959
  17. Systemic mesenchymal stem cell therapy for reduction of inflammatory burden in a patient with juvenile-onset rheumatoid arthritis and dialysis-dependent renal failure. Croatian medical journal · 13 Jun 2026 PMID 42286909
  18. Bioprinted dECM particles-laden microgels enhance the mesenchymal stromal cell paracrine effect for myocardial infarction treatment. Acta biomaterialia · 6 Jun 2026 PMID 42250666
  19. A microgel bone marrow model of mesenchymal stromal cell paracrine signaling supporting hematopoietic stem cell retention. Acta biomaterialia · 5 Jun 2026 PMID 42248284
  20. TLR9 agonists alleviate diabetic condition by promoting the maturation of differentiated bone marrow mesenchymal stem cells in rats. Pakistan journal of pharmaceutical sciences · 22 May 2026 PMID 42170982
  21. Hypoxia-preconditioned bone marrow mesenchymal stem cells alleviate acute liver failure in association with the VEGF/c-Met pathway. Molecular biology reports · 21 May 2026 PMID 42165955
  22. Platelet-rich plasma-primed bone marrow mesenchymal stem cell-derived exosomes inhibit neuronal apoptosis and autophagy, and promote nerve regeneration via the miR-29a-3p/PTEN/PI3K/Akt/mTOR axis after spinal cord injury. Journal of molecular histology · 21 May 2026 PMID 42165939
  23. Heat shock preconditioning potentiates the therapeutic efficacy of mesenchymal stem cells for traumatic brain injury. Biochemical and biophysical research communications · 20 May 2026 PMID 42161062

By study type

Clinical trials (1)
  1. Helping Underdeveloped Lungs with Cells (HULC-2): mesenchymal stromal cells in extreme preterm infants at risk of developing bronchopulmonary dysplasia - a study protocol of a phase 2 multicentre double blind randomised controlled trial in Canada. BMJ open · 6 Jul 2026 PMID 42409407
Observational studies and case reports (4)
  1. Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease. Cytotherapy · 2 Sept 2026 PMID 42685638
  2. Long-Term Survival, Illness Severity, and Time-to-Treatment Analysis in Dogs with Immune-Mediated Hemolytic Anemia Following Intravenous Allogeneic Mesenchymal Stem Cell Therapy: A Multicohort Follow-Up Study. Stem cells and development · 17 Jul 2026 PMID 42466752
  3. Intraventricular administration of SHED-derived mesenchymal stem cells in neonatal post- infectious hydrocephalus: a first-in-human case report. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 26 Jun 2026 PMID 42362959
  4. Systemic mesenchymal stem cell therapy for reduction of inflammatory burden in a patient with juvenile-onset rheumatoid arthritis and dialysis-dependent renal failure. Croatian medical journal · 13 Jun 2026 PMID 42286909
Human data, design not indexed (1)
  1. Responders vs. non-responders to mesenchymal stromal cells in knee osteoarthritis: Mechanistic correlates of donor cell and patient features. Stem cell reports · 6 Aug 2026 PMID 42561945
Preclinical: animal, cell and lab studies (16)
  1. The systemic administration of multipotent mesenchymal stromal cells alters the inflammatory response in the lung during murine polymicrobial sepsis. Cell and tissue research · 31 Oct 2026 PMID 42963429
  2. Can mesenchymal stem cell and retinoic acid therapies more effectively reduce lung damage due to bronchopulmonary dysplasia? Italian journal of pediatrics · 23 Oct 2026 PMID 42920189
  3. ABCB5⁺ mesenchymal stem cells enable high-ratio cellular augmentation of bone grafts without loss of osteogenic function. European journal of trauma and emergency surgery : official publication of the European Trauma Society · 3 Sept 2026 PMID 42690432
  4. Remodeling-phase wound-derived protein factors enhance mesenchymal stem cell function and improve diabetic wound healing. Molecular biology reports · 3 Sept 2026 PMID 42690285
  5. Gelatin Methacrylate as a Mesenchymal Stem Cell Delivery Vehicle: Experimental and Semi-Quantitative Evaluation Under Metabolic Stress. Macromolecular bioscience · 2 Sept 2026 PMID 42683595
  6. High-intensity interval training versus mesenchymal stem cells in amyloid-β-induced Alzheimer's disease: comparative effects on cognitive function,hippocampal inflammation, oxidative balance, and BDNF. Biochemical and biophysical research communications · 27 Aug 2026 PMID 42659862
  7. Dual-Reporter Gene-Based Multimodal Imaging for Tracking Mesenchymal Stem Cells in Diabetic Skin Wound Repair. Stem cell reviews and reports · 12 Aug 2026 PMID 42584542
  8. Aptamer-functionalized stiff hydrogel for enhanced BMSC enrichment and osteogenesis. PloS one · 16 Jul 2026 PMID 42461853
  9. A one-step surface engineering strategy based on PEG-EGCG to improve systemic delivery and survival of transplanted mesenchymal stromal cells. Journal of controlled release : official journal of the Controlled Release Society · 2 Jul 2026 PMID 42392407
  10. An injectable nanoreinforced hydrogel for combined GDNF-loaded nanoparticles and mesenchymal stem cell therapy in Parkinson's disease. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 1 Jul 2026 PMID 42386013
  11. Bioprinted dECM particles-laden microgels enhance the mesenchymal stromal cell paracrine effect for myocardial infarction treatment. Acta biomaterialia · 6 Jun 2026 PMID 42250666
  12. A microgel bone marrow model of mesenchymal stromal cell paracrine signaling supporting hematopoietic stem cell retention. Acta biomaterialia · 5 Jun 2026 PMID 42248284
  13. TLR9 agonists alleviate diabetic condition by promoting the maturation of differentiated bone marrow mesenchymal stem cells in rats. Pakistan journal of pharmaceutical sciences · 22 May 2026 PMID 42170982
  14. Hypoxia-preconditioned bone marrow mesenchymal stem cells alleviate acute liver failure in association with the VEGF/c-Met pathway. Molecular biology reports · 21 May 2026 PMID 42165955
  15. Platelet-rich plasma-primed bone marrow mesenchymal stem cell-derived exosomes inhibit neuronal apoptosis and autophagy, and promote nerve regeneration via the miR-29a-3p/PTEN/PI3K/Akt/mTOR axis after spinal cord injury. Journal of molecular histology · 21 May 2026 PMID 42165939
  16. Heat shock preconditioning potentiates the therapeutic efficacy of mesenchymal stem cells for traumatic brain injury. Biochemical and biophysical research communications · 20 May 2026 PMID 42161062
Unclassified: not yet indexed with MeSH (1)
  1. Mesenchymal Stromal Cells Fuel Immunometabolic Reprogramming of Type 2 Conventional Dendritic Cells to Alleviate Systemic Sclerosis. Arthritis & rheumatology (Hoboken, N.J.) · 5 Oct 2026 PMID 42834011